RxDoctor Payments Data

Sherri Brooks, NP

Family · Ringgold, GANPI 1952640229

Payments from drug & device makers

$1,785in general payments, 2019–2025

Across 101 payments — averaging $17.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$596
  • Novo Nordisk$365
  • Lilly USA, LLC$251
  • Pfizer$136
  • Xeris Pharmaceuticals, Inc.$104
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$76
  • plus $256 from 8 others

What the payments were for

  • Food & beverage$1,785100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,785 in reported general payments places this provider in the 75th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$39,523
Medicare patients
228
Services billed
1,176

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide11$11,545
Albuterol Sulfate HfaAlbuterol Sulfate134$3,789
Fluticasone Propionate176$2,423
Ventolin HfaAlbuterol Sulfate27$1,441
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav107$1,095
Cefdinir41$901
Prednisone124$551
Omeprazole40$407
Oseltamivir Phosphate12$376
Esomeprazole Magnesium16$359
Dicyclomine Hcl11$338
Azithromycin38$238
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst18$211
Cephalexin26$179
Mupirocin23$172

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$251$11,54511 claims
PfizerPaxlovid$136$012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,258 family providers in Georgia.

Other family in Ringgold

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →